These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 2076347

  • 1. [Recovery of nigrostriatal and mesolimbic dopaminergic system following administration of ganglioside in MPTP-treated mice].
    Date I, Asari S, Nishimoto A, Felten DL.
    No To Shinkei; 1990 Nov; 42(11):1035-40. PubMed ID: 2076347
    [Abstract] [Full Text] [Related]

  • 2. GM1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in MPTP-treated mice.
    Schneider JS, Kean A, DiStefano L.
    J Neurosci Res; 1995 Sep 01; 42(1):117-23. PubMed ID: 8531220
    [Abstract] [Full Text] [Related]

  • 3. Stereotaxic injection of GD1a ganglioside induces limited recovery of striatal dopaminergic system in MPTP-treated aging mice.
    Date I, Notter MF, Felten SY, Felten DL.
    J Neurosci Res; 1991 Apr 01; 28(4):525-30. PubMed ID: 1678435
    [Abstract] [Full Text] [Related]

  • 4. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
    Hadjiconstantinou M, Mariani AP, Neff NH.
    Brain Res; 1989 Apr 10; 484(1-2):297-303. PubMed ID: 2565752
    [Abstract] [Full Text] [Related]

  • 5. Exogenous GM1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice.
    Date I, Felten SY, Felten DL.
    Neurosci Lett; 1989 Dec 04; 106(3):282-6. PubMed ID: 2601883
    [Abstract] [Full Text] [Related]

  • 6. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.
    Mitsumoto Y, Watanabe A, Mori A, Koga N.
    Biochem Biophys Res Commun; 1998 Jul 30; 248(3):660-3. PubMed ID: 9703982
    [Abstract] [Full Text] [Related]

  • 7. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.
    Frohna PA, Rothblat DS, Joyce JN, Schneider JS.
    Synapse; 1995 Jan 30; 19(1):46-55. PubMed ID: 7709343
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
    Nishi K, Kondo T, Narabayashi H.
    No To Shinkei; 1987 Jul 30; 39(7):663-72. PubMed ID: 3314916
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.
    Schneider JS.
    J Neurosci Res; 1992 Jan 30; 31(1):112-9. PubMed ID: 1613817
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
    Gnanalingham KK, Smith LA, Hunter AJ, Jenner P, Marsden CD.
    Synapse; 1993 Jun 30; 14(2):184-94. PubMed ID: 8332947
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R, Muramatsu Y, Kato H, Watanabe Y, Imai Y, Itoyama Y, Araki T.
    Eur Neuropsychopharmacol; 2005 Jan 30; 15(1):57-67. PubMed ID: 15572274
    [Abstract] [Full Text] [Related]

  • 16. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
    Fornai F, Alessandrì MG, Torracca MT, Bassi L, Corsini GU.
    J Pharmacol Exp Ther; 1997 Oct 30; 283(1):100-7. PubMed ID: 9336313
    [Abstract] [Full Text] [Related]

  • 17. Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease.
    Shchepinov MS, Chou VP, Pollock E, Langston JW, Cantor CR, Molinari RJ, Manning-Boğ AB.
    Toxicol Lett; 2011 Nov 30; 207(2):97-103. PubMed ID: 21906664
    [Abstract] [Full Text] [Related]

  • 18. Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Joniec I, Ciesielska A, Kurkowska-Jastrzebska I, Przybylkowski A, Czlonkowska A, Czlonkowski A.
    Brain Res; 2009 Mar 19; 1261():7-19. PubMed ID: 19401171
    [Abstract] [Full Text] [Related]

  • 19. MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF).
    Date I, Notter MF, Felten SY, Felten DL.
    Brain Res; 1990 Aug 27; 526(1):156-60. PubMed ID: 1706636
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.